Emerging treatments for PTSD.

Judith Cukor, Josh Spitalnick, Joann Difede, Albert Rizzo, Barbara O Rothbaum

Journal: Clinical psychology review 2010;29(8):715-26

PMID: 19800725

Full Text on Elsevier Science View on PubMed

Abstract

Recent innovations in posttraumatic stress disorder (PTSD) research have identified new treatments with significant potential, as well as novel enhancements to empirically-validated treatments. This paper reviews emerging psychotherapeutic and pharmacologic interventions for the treatment of PTSD. It examines the evidence for a range of interventions, from social and family-based treatments to technological-based treatments. It describes recent findings regarding novel pharmacologic approaches including propranolol, ketamine, prazosin, and methylenedioxymethamphetamine. Special emphasis is given to the description of virtual reality and D-cycloserine as enhancements to prolonged exposure therapy.

Address: Weill Cornell Medical College, New York, NY 10065, USA. [email protected]

DOI: 10.1016/j.cpr.2009.09.001

Link outs

Free resources

Medical:

Subscription / membership required

Full Text Sources:

https://linkinghub.elsevier.com/retrieve/pii/S0272...

MeSH Terms: Cognitive Behavioral Therapy, Combat Disorders, Computer Simulation, Cycloserine, Humans, Implosive Therapy, Interpersonal Relations, Ketamine, Life Change Events, N-Methyl-3,4-methylenedioxyamphetamine, Prazosin, Propranolol, Stress Disorders, Post-Traumatic, Stress, Psychological, User-Computer Interface